Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001651431-17-000001
Filing Date
2017-02-16
Accepted
2017-02-16 16:08:15
Documents
1
Effectiveness Date
2017-02-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7361
  Complete submission text file 0001651431-17-000001.txt   8421
Mailing Address 1 BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address 1 BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-246410 | Film No.: 17617986